| Phenomenology and classification of dystonia: a consensus update A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ... Movement disorders 28 (7), 863-873, 2013 | 2484 | 2013 |
| Parkinson's disease BR Bloem, MS Okun, C Klein The Lancet 397 (10291), 2284-2303, 2021 | 2367 | 2021 |
| Genome-wide association study reveals genetic risk underlying Parkinson's disease J Simon-Sanchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ... Nature genetics 41 (12), 1308-1312, 2009 | 2244 | 2009 |
| Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ... Nature genetics 46 (9), 989-993, 2014 | 2068 | 2014 |
| Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ... The Lancet Neurology 7 (7), 583-590, 2008 | 1726 | 2008 |
| Genetics of Parkinson’s disease C Klein, A Westenberger Cold Spring Harbor perspectives in medicine 2 (1), a008888, 2012 | 1673 | 2012 |
| Parkin and PINK1 mitigate STING-induced inflammation DA Sliter, J Martinez, L Hao, XI Chen, N Sun, TD Fischer, JL Burman, Y Li, ... Nature 561 (7722), 258-262, 2018 | 1139 | 2018 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 956 | 2017 |
| LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews LJ Ozelius, G Senthil, R Saunders-Pullman, E Ohmann, A Deligtisch, ... New England Journal of Medicine 354 (4), 424-425, 2006 | 847 | 2006 |
| Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database CM Lill, JT Roehr, MB McQueen, FK Kavvoura, S Bagade, BMM Schjeide, ... PLoS genetics 8 (3), e1002548, 2012 | 621 | 2012 |
| Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease O Cooper, H Seo, S Andrabi, C Guardia-Laguarta, J Graziotto, ... Science translational medicine 4 (141), 141ra90-141ra90, 2012 | 564 | 2012 |
| Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells P Seibler, J Graziotto, H Jeong, F Simunovic, C Klein, D Krainc Journal of Neuroscience 31 (16), 5970-5976, 2011 | 476 | 2011 |
| A major lung cancer susceptibility locus maps to chromosome 6q23–25 JE Bailey-Wilson, CI Amos, SM Pinney, GM Petersen, M De Andrade, ... The American Journal of Human Genetics 75 (3), 460-474, 2004 | 468 | 2004 |
| The DYT1 phenotype and guidelines for diagnostic testing SB Bressman, C Sabatti, D Raymond, D De Leon, C Klein, PL Kramer, ... Neurology 54 (9), 1746-1753, 2000 | 435 | 2000 |
| Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes V Bonifati, CF Rohe, GJ Breedveld, E Fabrizio, M De Mari, C Tassorelli, ... Neurology 65 (1), 87-95, 2005 | 423 | 2005 |
| Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration B Dehay, A Ramirez, M Martinez-Vicente, C Perier, MH Canron, ... Proceedings of the National Academy of Sciences 109 (24), 9611-9616, 2012 | 403 | 2012 |
| LRRK2 in Parkinson disease: challenges of clinical trials E Tolosa, M Vila, C Klein, O Rascol Nature Reviews Neurology 16 (2), 97-107, 2020 | 400 | 2020 |
| PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling VA Morais, D Haddad, K Craessaerts, PJ De Bock, J Swerts, S Vilain, ... Science 344 (6180), 203-207, 2014 | 379 | 2014 |
| Lysosomal impairment in Parkinson's disease B Dehay, M Martinez‐Vicente, GA Caldwell, KA Caldwell, Z Yue, ... Movement Disorders 28 (6), 725-732, 2013 | 369 | 2013 |
| Deciphering the role of heterozygous mutations in genes associated with parkinsonism C Klein, K Lohmann-Hedrich, E Rogaeva, MG Schlossmacher, AE Lang The Lancet Neurology 6 (7), 652-662, 2007 | 359 | 2007 |
